Cargando…

Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity

OBJECTIVE: Objectives of this study were to compare expression of Programmed Death-Ligand 1(PD-L1) protein in oral squamous cell carcinoma (OSCC) and oral potentially malignant disorder (OPMD) cases; and to compare the PD-L1 protein expression in histological grades of OSCC and also in OPMD’s with D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeed, Saleha, Rauf, Fozia, Iqbal, Fatima, Khan, Abbas Saleem, Khan, Amara Hayat, Alamgeer, Rabia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971448/ https://www.ncbi.nlm.nih.gov/pubmed/36579984 http://dx.doi.org/10.31557/APJCP.2022.23.12.4039

Ejemplares similares

Apoptotic Index and Proliferative Index in Premalignant and Malignant Squamous Cell Lesions of the Oral Cavity
por: Viswanathan, Vidya, et al.
Publicado: (2015)

Chemoprevention of premalignant and malignant lesions of oral cavity: Recent trends
por: Bodhade, Ashish S., et al.
Publicado: (2013)

Cyclin D1 in oral premalignant lesions and oral squamous cell carcinoma: An immunohistochemical study
por: Moharil, Rohit Balwant, et al.
Publicado: (2020)

Metallothioneins and Megalin Expression Profiling in Premalignant and Malignant Oral Squamous Epithelial Lesions
por: Zulijani, Ana, et al.
Publicado: (2021)

E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study
por: Kalaimani, Gnanambigai, et al.
Publicado: (2023)

Betel nut chewing, oral premalignant lesions, and the oral microbiome
por: Hernandez, Brenda Y., et al.
Publicado: (2017)

Immunological and classical subtypes of oral premalignant lesions
por: Foy, Jean-Philippe, et al.
Publicado: (2018)

Oral Premalignancy
por: Hume, W.
Publicado: (1981)

Status and Determinants of Early Detection of Oral Premalignant and Malignant Lesions in India
por: Shruti, Tulika, et al.
Publicado: (2023)

Efficacy of oral brush cytology in the evaluation of the oral premalignant and malignant lesions
por: Babshet, M, et al.
Publicado: (2011)

Local Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment
por: Levingston, Corinne A., et al.
Publicado: (2017)

Mast Cells and Angiogenesis in Oral Malignant and Premalignant Lesions
por: Michailidou, E.Z, et al.
Publicado: (2008)

Estimation of salivary sialic acid in oral premalignancy and oral squamous cell carcinoma
por: Chaudhari, Vishakha, et al.
Publicado: (2016)

Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity
por: Nomura, Hitomi, et al.
Publicado: (2008)

An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma
por: Woodford, Danielle, et al.
Publicado: (2014)

Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD‐1 antibodies
por: Levingston, Corinne A., et al.
Publicado: (2017)

Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions
por: Saini, Rajan, et al.
Publicado: (2016)

Assessment of the oral health seeking behavior of patients with premalignant lesions
por: Deolia, Shravani G., et al.
Publicado: (2020)

Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study
por: Humayun, S., et al.
Publicado: (2011)

Long non-coding RNAs are novel players in oral inflammatory disorders, potentially premalignant oral epithelial lesions and oral squamous cell carcinoma (Review)
por: Zhang, Kaiying, et al.
Publicado: (2020)

T-Cell Infiltration and Immune Checkpoint Expression Increase in Oral Cavity Premalignant and Malignant Disorders
por: Surendran, Subin, et al.
Publicado: (2022)

Surgery management of oral cavity premalignancy needs risk stratification and randomized controlled trials
por: Liu, Wei, et al.
Publicado: (2023)

Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions
por: Mehrotra, Ravi, et al.
Publicado: (2006)

Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions
por: Xia, Juan, et al.
Publicado: (2012)

Oral premalignant lesions: epidemiological and clinical analysis in the northern Polish population
por: Starzyńska, Anna, et al.
Publicado: (2014)

Mast cells and angiogenesis in malignant and premalignant oral lesions: An immunohistochemical study
por: Laishram, Daisy, et al.
Publicado: (2017)

Role of IL-23 signaling in the progression of premalignant oral lesions to cancer
por: Caughron, Blaine, et al.
Publicado: (2018)

The Effect of Photodynamic Therapy on Oral-Premalignant Lesions: A Systematic Review
por: Choudhary, Ruchika, et al.
Publicado: (2022)

Whether cryosurgery for oral premalignant lesions influences the outcome of malignant transformation
por: Liu, Wei, et al.
Publicado: (2023)

Analysis of Ki-67 Expression in Oral Premalignant Lesions and Normal Oral Mucosa: An Immunohistochemical Study
por: Beevi, Basheer H., et al.
Publicado: (2019)

Oral Squamous Cell Carcinoma Clinico-pathological features in relation to Tumor Stage; AJCC 2018 perspective
por: Khan, Nauman Rauf, et al.
Publicado: (2023)

“SKILL TO KILL” – Oral cancer and potentially premalignant oral epithelial lesions (PPOELs): A survey approach. Emerging of a new system and professionals
por: Khan, Nawal, et al.
Publicado: (2019)

Estimation of cortisol levels in patients with premalignant disorders and oral squamous cell carcinoma
por: Sharma, Priyanka, et al.
Publicado: (2018)

Adjunctive aids for the detection of oral premalignancy
por: Charanya, D., et al.
Publicado: (2016)

Retraction: Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions
por: Mehrotra, Ravi, et al.
Publicado: (2012)

Progress risk assessment of oral premalignant lesions with saliva miRNA analysis
por: Yang, Ya, et al.
Publicado: (2013)

Molecular Imaging of Oral Premalignant and Malignant Lesions Using Fluorescently Labeled Lectins
por: Baeten, John, et al.
Publicado: (2014)

Evaluation of mast cells in oral premalignant and malignant lesions: A histochemical study
por: Singh, Shreya, et al.
Publicado: (2018)

Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort
por: Gomez-Armayones, Sara, et al.
Publicado: (2019)

Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions
por: Gutkind, J. Silvio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s8tdbnggif26nf0ufoaidfsouj